Connection
Michael Szarek to Serum Amyloid A Protein
This is a "connection" page, showing publications Michael Szarek has written about Serum Amyloid A Protein.
|
|
Connection Strength |
|
 |
|
 |
|
0.086 |
|
|
|
-
Kinlay S, Schwartz GG, Olsson AG, Rifai N, Szarek M, Waters DD, Libby P, Ganz P. Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study. Arterioscler Thromb Vasc Biol. 2008 Jan; 28(1):142-7.
Score: 0.073
-
Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation. 2003 Sep 30; 108(13):1560-6.
Score: 0.014